Skip to main content

Zusammenfassung

Zur Gruppe der Anästhetika gehören Substanzen mit sehr unterschiedlichen chemischen Strukturformeln (◘Abb. 2.1). Hierzu zählen Hydrocarbone (Chloroform, Halothan), Derivate des Ether (Isofluran, Desfluran, Sevofluran), Phenole (Propofol), Imidazolderivate (Etomidat, Dexmedetomidin), Phencyclidine (Ketamin), Steroide (Alphaxalone), Barbiturate (Thiopental), Benzodiazepine (Midazolam) und Edelgase (Xenon).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Antkowiak, B (2001) How do gerneral anaesthetis work? Neuro-wissenschaften 88:201–213

    Article  CAS  Google Scholar 

  2. Cascorbi I (2006) Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 112:457–473

    Article  PubMed  CAS  Google Scholar 

  3. Daly AK (2009) Pharmacogenomics of anticoagulants: steps toward personal dosage. Genome Med 1:10

    Article  PubMed  Google Scholar 

  4. Drago A, De Ronchi D, Serretti A (2009) Pharmacogenetics of antidepressant response: an update. Hum Genomics 3:257–274

    Article  PubMed  CAS  Google Scholar 

  5. Drexler B, Grasshoff C, Rudolph U, Unertl K, Antkowiak B (2006) The GABA(A) receptor family : Possibilities for the development of better anesthetics. Anaesthesist 55:287–295

    Article  PubMed  CAS  Google Scholar 

  6. Eichelbaum M, Ingelman-Sundberg M, Evans WE (2006) Pharmacogenomics and individualized drug therapy. Annu Rev Med 57: 119–137

    Article  PubMed  CAS  Google Scholar 

  7. Franks NP (2006) Molecular targets underlying general anaesthesia. Brit J Pharmacol 147: S72–S81

    Article  CAS  Google Scholar 

  8. Grasshoff C, Rudolph U, Antkowiak B (2005) Molecular and systemic mechanisms of general anaesthesia: the,multi-site and multiple mechanisms' concept. Curr Opin Anaesth 18:386–391

    Article  Google Scholar 

  9. Hemmings HC, Akabas MH, Goldstein PA et al. (2005) Emerging molecular mechanisms of general anesthetic action. Trends Pharmacol Sci 26:503–510

    Article  PubMed  CAS  Google Scholar 

  10. Hughes AR, Spreen WR, Mosteller M et al. (2008) Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility. Pharmacogenomics J 8:365–374

    Article  PubMed  CAS  Google Scholar 

  11. Kaiser R, Sezer O, Papies A et al. (2002) Patient-tailored anti-emetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. J Clin Oncol 20:2805–2811

    Article  PubMed  CAS  Google Scholar 

  12. Klotz U (2006) Clinical impact of CYP2C19 polymorphism on the action of proton pump inhibitors: a review of a special problem. Int J Clin Pharmacol Ther 44:297–302

    PubMed  CAS  Google Scholar 

  13. La Du BN, Bartels CF, Nogueira CP, Arpagaus M, Lockridge O (1991) Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing. Cell Mol Neurobiol 11:79–89

    Article  PubMed  CAS  Google Scholar 

  14. Liggett SB, Mialet-Perez J, Thaneemit-Chen S et al. (2006) A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci USA 103:11288–11293

    Article  PubMed  CAS  Google Scholar 

  15. Link E, Parish S, Armitage J et al. (2008) SLCO1B1 variants and statin-induced myopathy-a genomewide study. N EngI J Med 359:789–799

    Article  CAS  Google Scholar 

  16. Loscher W, Delanty N (2009) MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion. Pharma-cogenomics 10:711–713

    Article  Google Scholar 

  17. Lotsch J, Geisslinger G (2005) Are mu-opioid receptor polymorphisms important for clinical opioid therapy? Trends Mol Med 11:82–89

    Article  PubMed  Google Scholar 

  18. Lotsch J, Geisslinger G (2006) Current evidence for a genetic modulation of the response to analgesics. Pain 121:1–5

    Article  PubMed  Google Scholar 

  19. Mariani G, Fasolo A, De Benedictis E, Gianni L (2009) Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer. Nat Clin Pract Oncol 6: 93–104

    Article  PubMed  CAS  Google Scholar 

  20. Nagele P, Zeugswetter B, Wiener C et al. (2008) Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia. Anesthesiology 109:36–43

    Article  PubMed  CAS  Google Scholar 

  21. Niemi M (2007) Role of OATP transporters in the disposition of drugs. Pharmacogenomics 8:787–802

    Article  PubMed  CAS  Google Scholar 

  22. Rau T, Wuttke H, Michels LM et al. (2009) Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study. Clin Pharmacol Ther 85:269–272

    Article  PubMed  CAS  Google Scholar 

  23. Robinson RL, Anetseder MJ, Brancadoro V et al. (2003) Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing? Eur J Hum Genet 11:342–348

    Article  PubMed  CAS  Google Scholar 

  24. Rudolph U, Antkowiak B (2004) Molecular and neuronal substrates for general anaesthetics. Nature Rev Neuroscience 5: 709–720

    Article  CAS  Google Scholar 

  25. Simon T, Verstuyft C, Mary-Krause M et al. (2009) Genetic determinants of response to clopidogrel and cardiovascular events. N EngI J Med 360:363–375

    Article  CAS  Google Scholar 

  26. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB (2002) Synergistic polymorphisms of betal- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347:1135–1142

    Article  PubMed  CAS  Google Scholar 

  27. Sonner JM, Antognini JF, Dutton RC et al. (2003) Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth Anal 97:718–740

    Article  CAS  Google Scholar 

  28. Steimer W, Zopf K, von Amelunxen S et al. (2005) Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy. Clin Chem 51:376–385

    Article  PubMed  CAS  Google Scholar 

  29. Urban BW (2002) Current assessment of targets and theories of anaesthesia. Br J Anaesth 89:165–183

    Google Scholar 

  30. Urban BW, Bleckwenn M (2002) Concepts and correlations relevant to general anaesthesia. Br J Anaesth 89:3–16

    Article  PubMed  CAS  Google Scholar 

  31. Urban BW, Bleckwenn M, Barann M (2006) Interactions of anesthetics with their targets: Non-specific, specific or both? Pharmacology therapeutics 111: 729–770

    Article  PubMed  CAS  Google Scholar 

  32. Yin T, Maekawa K, Kamide K et al. (2008) Genetic variations of CYP2C9 in 724 Japanese individuals and their impact on the antihypertensive effects of losartan. Hypertens Res 31:1549–1557

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Antkowiak, B., Cascorbi, I. (2011). Pharmakodynamik. In: Tonner, P.H., Hein, L. (eds) Pharmakotherapie in der Anästhesie und Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79156-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79156-0_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79155-3

  • Online ISBN: 978-3-540-79156-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics